Back to Clinical Trials
Phase 3Recruiting

The Cancer of the Pancreas Screening-5 CAPS5)Study

Sponsored by Johns Hopkins University

About this study

Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at their site.

The Sub Investigator at each site will be responsible for internal monitoring at their site. The site sub Investigator and study team will report any serious adverse events to Principal Investigator and annually report adverse events.

Where this study is enrolling (9)

Show all 9 locations

  • Columbia University Medical Center

    New York, New York

    I'm interested

  • Case Comprehensive Cancer Center, Case Western Medical Reserve

    Cleveland, Ohio

    I'm interested

  • University of Pennsylvania

    Philadelphia, Pennsylvania

    I'm interested

  • University of Pittsburgh

    Pittsburgh, Pennsylvania

    I'm interested
Who can participate

Inclusion criteria

  • ✓Hereditary Pancreatitis or
  • ✓Peutz-Jeghers Syndrome or
  • ✓Strong family history of pancreas cancer on one side of the family tree or
  • ✓Confirmed germline mutation carrier (BRCA2, FAMMM (CDKN2A/p16), PALB2, BRCA1, ATM, HNPCC, Lynch Syndrome (hMLH1, hMSH2, PMS2, hMSH6, EpCAM) PRSS1, PRSS2, R122H, N291l, SPINK1, CFTR
  • ✓Endoscopic evaluation of pancreas scheduled

Exclusion criteria

  • ✕Medical comorbidities or coagulopathy that contraindicate endoscopy
  • ✕Prior surgery that prevent optimal endoscopic ultrasound such as partial or complete gastrectomy with Bilroth or Roux-en-Y anastomosis
  • ✕Stricture or obstruction in the upper GI tract that does not allow passage of the echoendoscope
  • ✕Poor performance status
  • ✕Inability to provide informed consent
  • ✕Pregnancy.

Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.